Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users

NCT ID: NCT07082517

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-03

Study Completion Date

2022-03-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Withings Body Cardio is capable to measure PWV in the right and left lower limbs. The hypothesis of this study is a significant difference in PWV between the right and left lower limbs measured by the device may be the sign of people with more risk factors that may lead to a PAD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Active users of WITHINGS Body Cardio bathroom scale will be invited to participate to the study. In case of a positive answer, the user will receive an electronic questionnaire about its health and medical history and the data recorded from the previous six months on his/her Body Cardio bathroom scale will be collected in the study.

Once consent has been given, the user's data collectedby the WITHINGS Body Cardio scales will be extracted anonymously and associated with the answers to the questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PAD - Peripheral Arterial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Significant PWV difference

Population with a significant difference PWV between the right and left lower limbs.

Percentage analysis

Intervention Type OTHER

Analysis the percentage of the population with risk factors that may lead to a PAD.

No significant PWV difference

Population with no significant difference PWV between the right and left lower limbs.

Percentage analysis

Intervention Type OTHER

Analysis the percentage of the population with risk factors that may lead to a PAD.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percentage analysis

Analysis the percentage of the population with risk factors that may lead to a PAD.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Active and regular user of the device
* Adult participant
* Participant who agreed to participate in the study, after reading the study information letter
* Participant living in France

Exclusion Criteria

* User who didn't agreed to participate to the study after reading the study information letter
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Withings

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pierre Boutouyrie, Pr

Role: PRINCIPAL_INVESTIGATOR

Georges Pompidou European Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Withings

Issy-les-Moulineaux, Withings, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02620-39

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.